A Quick Tour: Insights From inside the Cannes Pharma Jury
By Christopher Charles, Executive Creative Director, 21GRAMS, and 2026 Pharma Lions Juror I just spent a week in a room most people never get to...
Featured News
What AI is telling the market now that ASCO is over
Generative Engine Optimization (GEO) looks at how AI assistants like ChatGPT and OpenEvidence answer real questions about a brand, trial, or therapy area, since these...
Real Chemistry Unifies Omnichannel Offering as Real Chemistry Media, a Technology-led, Healthcare-focused Practice of the Future
Completed integration of recent acquisitions of Greater Than One and Spring & Bond strengthens Real Chemistry’s media and omnichannel offering Company advances its first-in-class, AI-powered...
GLP-1 receptor agonists: Did anyone really see this coming?
by Ujwal Pyati, PhD, Chief Medical Officer Working in healthcare provides no end to excitement, particularly when we partner with companies who are generating amazing...
Tailored by the Trace: How Measurable Residual Disease is Helping Guide Hematology Treatment
by Marc Astick, Associate Scientific Director and Rebecca Lamb, Senior Group Director Ask experts in hematology what they’re working towards and you’re likely to hear...
Scientific Trust Is Becoming Medical Affairs’ Most Valuable Asset
by Heather Shawcross, Associate Director, Medical Strategy, EMEA Strategy, Scientific & Medical The value challenge isn’t new. The environment is. Medical Affairs is the strategic...
Real Chemistry Appoints Healthcare Industry Leaders Frank Clyburn and Chris Fikry to Board of Directors
New independent directors bring deep experience in commercialization, data-driven transformation and growth NEW YORK, May 28, 2026 — Real Chemistry, a leader in AI-driven insights...
What Happens at ASCO Doesn’t Stay at ASCO
by Stephanie Holbrook, Senior Vice President, Activation, starpower Not that long ago, the conversation around a major ASCO readout unfolded over time. Data was presented...
AI on the Clinical Front Line: The New Visibility Challenge for Biotechs
By Andrew Nelson, Senior Director, Integrated Intelligence + Analytics Social Listening In the AI era, time pressed clinicians are already changing how they keep up...